The following vaccines may be administered on the NHS for the purposes of travel, if clinically appropriate:
Diphtheria/ Tetanus/ Polio
The following vaccines should not be prescribed on the NHS exclusively for the purposes of travel, but may be prescribed on the NHS for all other indications listed in Immunisation Against Infectious Disease (The Green Book)
These vaccines should continue to be recommended for travel, but the individual traveller will need to bear the cost of the vaccination.
The polio vaccine is only given as part of combined products:
● diphtheria/tetanus/acellular pertussis/inactivated polio vaccine/
Haemophilus influenzae type b (DTaP/IPV/Hib)
● diphtheria/tetanus/acellular pertussis/inactivated polio vaccine (DTaP/
IPV or dTaP/IPV)
● tetanus/diphtheria/inactivated polio vaccine (Td/IPV).
Rotavirus vaccine (Rotarix®)
Tick-borne encephalitis vaccine
Polysaccharide vaccine for injection (Typhim Vi®, Typherix®)
The APC notes that the informed use of unlicensed medicines or of licensed medicines for unlicensed applications (‘off-label’ use) is often necessary in paediatric practice.
The APC advises GPs to consider specialist prescribing recommendations for Green and Amber medicines that are not subject to ESCAs or RICaDs in combination with the information provided in the BNFC which goes beyond that of marketing authorisations. The BNFC has been designed for rapid reference and the information presented has been carefully selected to aid decisions on prescribing.
Medicines suitable for routine use within primary care. Initiation and maintenance of prescribing by Specialists, GPs and other qualified clinicians.
Amber Specialist Initiation: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate. This may be supported by a RICaD, annotated within the formulary entry.
Amber Specialist Recommendation: Initiation and maintenance of prescribing in Primary Care following recommendation from a Specialist.
Amber Shared Care: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing, in accordance with an ESCA, annotated within the formulary entry.
Medicines for initiation and maintenance prescribing by Specialists only.
Non-formulary Medicines which APC/Trust DTC has actively reviewed and do not recommend for use.
Positive NICE TA and/or awaiting local clarification on place in therapy; Please contact your Medicines Optimisation team for more information.
The term 'Specialist' refers to Consultants, General Practitioners and Independant Prescribers with a Specialist Interest.